Texas V. Epic: Market Definition and Whataburger Edition

Key Takeaways

• Texas chose state court to sidestep federal pleading standards
• Epic attacks Texas’s split EHR market as artificial gerrymandering
• Metrics like “lives covered” deemed irrelevant for market share
• Aftermarket claim hinges on shaky fore‑market definition
• Outcome could reshape antitrust approach for health‑tech firms

Summary

Texas filed its antitrust suit against Epic Systems in state court to avoid federal consolidation and the stricter Twombly/Iqbal pleading standards. Epic’s motion to dismiss challenges the state’s market definition, arguing that the split between acute‑care and academic hospital EHR database markets is artificial and that the metrics used, such as “lives covered,” are irrelevant. The company also disputes the aftermarket gatekeeper theory, saying the fore‑market is poorly defined. The case highlights how procedural choices and market framing can determine the fate of high‑stakes health‑tech litigation.

Pulse Analysis

The Texas v. Epic dispute underscores a tactical shift in antitrust litigation, with the state opting for a Texas court to sidestep the federal Twombly/Iqbal thresholds that often dismiss cases early. By filing under the Texas Fair Competition Act, Texas hopes to benefit from a more permissive pleading standard that focuses on plausibility rather than detailed evidence. This procedural maneuver also prevents the case from being merged with parallel federal actions, allowing the AG to control timing and venue while signaling to other states that state courts can be viable arenas for complex health‑tech antitrust battles.

At the heart of the dispute lies the definition of the relevant market. Texas framed the market as a standalone "EHR Database Software" segment and further divided it into acute‑care hospitals and academic medical centers. Epic countered that this segmentation is a classic case of market gerrymandering, noting that buyers purchase integrated EHR platforms, not isolated databases, and that pricing, customers, and vendors are identical across the two groups. The state’s reliance on unconventional metrics—such as the percentage of patients with an Epic record—fails to reflect traditional B2B indicators like hospital bed counts, weakening any claim of monopoly power. By dismantling these measures, Epic aims to show that the alleged market shares fall well below the thresholds courts typically require for monopolization findings.

The aftermarket argument adds another layer of complexity. Epic argues that the alleged gatekeeper power over third‑party applications collapses without a solid fore‑market definition, echoing the logic from Epic Games v. Apple. Moreover, the claim that hospitals were unaware of restrictive data‑access terms is unpersuasive, given the extensive negotiations and disclosures involved in EHR contracts. If the court rejects Texas’s market boundaries and aftermarket theory, the decision could reverberate across the health‑tech industry, signaling that plaintiffs must craft robust, economically sound market definitions before pursuing antitrust relief against dominant EHR vendors.